Cases & Deals

  • Home
  • Practices
  • Takeover of Biotest AG by Chinese strategic investor Creat Group

Share

Takeover of Biotest AG by Chinese strategic investor Creat Group

January 2018

Client(s) OGEL GmbH

Jones Day advised OGEL GmbH as holder of 50.61 percent of the Ordinary Shares in Biotest AG, Germany, in connection with the acquisition of Biotest by way of a public takeover offer made by a company controlled by CREAT Group, China. The enterprise value of Biotest is €1.203 billion. Biotest is a global company that supplies plasma protein products and biotherapeutic drugs.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.